{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:49:04Z","timestamp":1761094144717,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbmt.2015.04.026","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T21:18:14Z","timestamp":1430947094000},"page":"1515-1523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societ\u00e9 Fran\u00e7aise de Greffe de Moelle et Therapie Cellulaire"],"prefix":"10.1016","volume":"21","author":[{"given":"Erick","family":"Xavier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan J.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels S.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Deconinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Veelken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Van Gelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regis","family":"Peffault de Latour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanderson","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2015.04.026_bib1","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib2","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2011-11-312421","article-title":"Risk categories and refractory CLL in the era of chemoimmunotherapy","volume":"119","author":"Zenz","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib3","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1200\/JCO.2009.27.8762","article-title":"TP53 mutation and survival in chronic lymphocytic leukemia","volume":"28","author":"Zenz","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib4","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1182\/blood-2005-12-051458","article-title":"Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia","volume":"109","author":"Wierda","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib6","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1200\/JCO.2011.34.7872","article-title":"Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia","volume":"29","author":"Trbusek","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2141.2009.07982.x","article-title":"A\u00a0comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia","volume":"148","author":"Van Dyke","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.leu.2404441","article-title":"Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus","volume":"21","author":"Dreger","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.04.026_bib9","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/cncr.24329","article-title":"Treatment of fludarabine-refractory chronic lymphocytic leukemia","volume":"115","author":"Tsimberidou","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2015.04.026_bib10","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1200\/JCO.2005.04.531","article-title":"Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia","volume":"23","author":"Moreno","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.exphem.2012.10.008","article-title":"Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: Long-term prospective multicenter study","volume":"41","author":"Michallet","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib13","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2003.12.011","article-title":"Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group","volume":"21","author":"Schetelig","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/sj.leu.2403745","article-title":"Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis","volume":"19","author":"Dreger","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.04.026_bib15","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2005.04.569","article-title":"Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia","volume":"23","author":"Sorror","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib17","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2015.04.026_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2015.04.026_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0Roy Stat Soc Ser B"},{"key":"10.1016\/j.bbmt.2015.04.026_bib21","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib22","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3324\/haematol.2010.027839","article-title":"Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia","volume":"96","author":"Bizzetto","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.04.026_bib24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbmt.2010.06.011","article-title":"Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by Eurocord and the aplastic anemia working party of the European Group for Blood and Marrow Transplant","volume":"17","author":"Peffault de Latour","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/bmt.2012.150","article-title":"Race\/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization","volume":"48","author":"Pidala","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"Bashey","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib27","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2008-10-183723","article-title":"Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery","volume":"113","author":"Dodero","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2007.15.8865","article-title":"Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation","volume":"27","author":"Rodrigues","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3324\/haematol.2013.088997","article-title":"Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood","volume":"99","author":"Rodrigues","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.04.026_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1445-5994.2008.01825.x","article-title":"Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes","volume":"39","author":"Bradstock","year":"2009","journal-title":"Intern Med J"},{"key":"10.1016\/j.bbmt.2015.04.026_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/leu.2013.259","article-title":"Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT","volume":"28","author":"Ruggeri","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.04.026_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib34","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood-2010-08-300491","article-title":"Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts","volume":"117","author":"Avery","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib35","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1182\/blood-2009-10-249219","article-title":"The impact of anti-HLA antibodies on unrelated cord blood transplantations","volume":"116","author":"Takanashi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib36","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3324\/haematol.2012.077685","volume":"98","author":"Ruggeri","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.04.026_bib37","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1182\/blood-2011-05-355263","article-title":"Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation","volume":"118","author":"Cutler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib38","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2002-11-3337","article-title":"Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning","volume":"102","author":"Barker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","article-title":"Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group","volume":"337","author":"Gluckman","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.04.026_bib40","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2008-07-163238","article-title":"Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors","volume":"113","author":"MacMillan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib41","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bbmt.2013.02.008","article-title":"Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match","volume":"19","author":"Ponce","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/bmt.2012.243","article-title":"Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin","volume":"48","author":"Ostronoff","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib43","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia","volume":"351","author":"Laughlin","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.04.026_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbmt.2014.10.024","article-title":"Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation","volume":"21","author":"Cassaday","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib45","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.leu.2402905","article-title":"Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning","volume":"17","author":"Dreger","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.04.026_bib46","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia","volume":"351","author":"Rocha","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.04.026_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/14653240701231014","article-title":"Immune reconstitution after unrelated cord blood transplantation","volume":"9","author":"Szabolcs","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2015.04.026_bib48","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3324\/haematol.2014.109280","article-title":"Engraftment kinetics and graft failure after single umbilical cord blood transplantation using myeloablative conditioning regimen","volume":"99","author":"Ruggeri","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.04.026_bib49","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1399-3062.2011.00632.x","article-title":"Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases","volume":"13","author":"Ruggeri","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.bbmt.2015.04.026_bib50","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2007.15.4757","article-title":"Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"26","author":"Sorror","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib51","first-page":"S35","article-title":"PH-O065: R-DHAP immune-chemotheray is an effective remission-induction treatment for fludarabine refractory CLL patients and allows the majority to proceed to allogeneic stem cell transplantation - results of the prospective multi center HOVON 88 trial","volume":"49","author":"Van Gelder","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/ehm.10.24","article-title":"Strategies to enhance umbilical cord blood stem cell engraftment in adult patients","volume":"3","author":"Delaney","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2014.00068","article-title":"Improving engraftment and immune reconstitution in umbilical cord blood transplantation","volume":"5","author":"Danby","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib54","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1200\/JCO.2008.16.2982","article-title":"Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis","volume":"26","author":"Schetelig","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1 Suppl","key":"10.1016\/j.bbmt.2015.04.026_bib55","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.bbmt.2010.10.031","article-title":"Minimal residual disease following allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Kroger","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2015.04.026_bib56","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/leu.2013.52","article-title":"Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia","volume":"27","author":"Logan","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.04.026_bib57","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.exphem.2013.04.015","article-title":"Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia","volume":"41","author":"Shaffer","year":"2013","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/leu.2012.228","article-title":"Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome","volume":"27","author":"Brown","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2015.04.026_bib59","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","article-title":"Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia","volume":"73","author":"Sullivan","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib60","first-page":"896","article-title":"Allogeneic hematopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse","volume":"83","author":"Zikos","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2015.04.026_bib61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0041-1345(96)00443-5","volume":"29","author":"Ringd\u00e9on","year":"1997","journal-title":"Transpl Proc"},{"key":"10.1016\/j.bbmt.2015.04.026_bib62","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1182\/blood-2011-12-400630","article-title":"Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes","volume":"119","author":"Brunstein","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib63","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1182\/blood-2009-05-220525","article-title":"Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units","volume":"114","author":"Verneris","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib64","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2010-03-275420","article-title":"Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial","volume":"116","author":"Dreger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2015.04.026_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1400376","article-title":"Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia","volume":"371","author":"Byrd","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.04.026_bib66","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1200\/JCO.2014.56.2025","article-title":"Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor","volume":"33","author":"Kochenderfer","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib67","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Woyach","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2015.04.026_bib68","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bbmt.2008.09.001","article-title":"The effect of in\u00a0vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia","volume":"14","author":"Delgado","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2015.04.026_bib69","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.cco.0000357473.58411.1b","article-title":"Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies","volume":"21","author":"Rocha","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2015.04.026_bib70","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1182\/blood-2008-10-184093","article-title":"Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation","volume":"113","author":"Bachanova","year":"2009","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879115003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:52:35Z","timestamp":1761058355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879115003225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1083879115003225"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.04.026","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societ\u00e9 Fran\u00e7aise de Greffe de Moelle et Therapie Cellulaire","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2015.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}